Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Return on Sales: 2020-2025

Historic Return on Sales for Eton Pharmaceuticals (ETON) over the last 6 years, with Sep 2025 value amounting to -0.12%.

  • Eton Pharmaceuticals' Return on Sales fell 3.00% to -0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.12%, marking a year-over-year decrease of 3.00%. This contributed to the annual value of -0.10% for FY2024, which is 7.00% down from last year.
  • As of Q3 2025, Eton Pharmaceuticals' Return on Sales stood at -0.12%, which was down 26.04% from -0.10% recorded in Q2 2025.
  • Eton Pharmaceuticals' 5-year Return on Sales high stood at 0.07% for Q3 2023, and its period low was -1.14% during Q1 2021.
  • Moreover, its 3-year median value for Return on Sales was -0.10% (2025), whereas its average is -0.08%.
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 10,089bps in 2021, then crashed by 39bps in 2022.
  • Over the past 5 years, Eton Pharmaceuticals' Return on Sales (Quarterly) stood at -0.09% in 2021, then slumped by 39bps to -0.48% in 2022, then soared by 46bps to -0.02% in 2023, then fell by 8bps to -0.10% in 2024, then decreased by 3bps to -0.12% in 2025.
  • Its Return on Sales was -0.12% in Q3 2025, compared to -0.10% in Q2 2025 and -0.14% in Q1 2025.